Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001783904-22-000002
Filing Date
2022-09-20
Accepted
2022-09-20 09:44:52
Documents
1
Effectiveness Date
2022-09-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4805
  Complete submission text file 0001783904-22-000002.txt   5851
Mailing Address 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA 19104 (206) 949-4956
Trevarx Biomedical, Inc. (Filer) CIK: 0001783904 (see all company filings)

EIN.: 814441936 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-459264 | Film No.: 221252225